Special Counsel Brian Sylvester was quoted in a Food Navigator-USA article, “FDA report on CBD seen as ‘disappointing’ recap of status quo,” about a report to Congress on CBD by FDA Commissioner Dr. Stephen Hahn.
Sylvester said the report suggests that FDA may be more focused on dietary supplements as a lawful regulatory pathway. “With the release of FDA’s report, we now know that FDA currently views dietary supplements as a potentially more viable pathway than food,” he said.
Related News
18 April 2024
In the News
Lynn Gandhi Unravels Tax Challenges in Hybrid Work Environments
Foley & Lardner LLP partner Lynn Gandhi offers insights on the taxation challenges a hybrid work environment can pose for human resources and payroll in the Reuters article "Tax attorney: Navigating the nuances of taxation in hybrid work arrangements.”
17 April 2024
In the News
Steven Barth on Allure of Take-Private Deals – 'Public markets aren’t what they’re cracked up to be'
Foley & Lardner LLP partner Steven Barth offers extensive insight on the growing trend of family-owned consumer and retail businesses aiming to go private in the Axios article, “Family-owned companies see allure in take-private deals.”
17 April 2024
In the News
Christopher Ward on Federal Arbitration Act – ‘It matters what a worker does’
Foley & Lardner LLP partner Christopher Ward is quoted in the Law360 article, “Airplane Servicers Nod to Justices, Reiterate That Fueling Isn't Interstate Work.”